Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Meredith

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Is cancer related to hypertension or to its treatment?A F Lever, D J Hole, C R Gillis, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failureC W Howden, C D Payton, P A Meredith, et al.
British Journal of Clinical Pharmacology|October 1, 1991
A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteersJ D Gemmill, C A Howie, P A Meredith, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?A F Lever, D G Beevers, D J Hole, et al.
Journal of Hypertension|April 9, 1998
Cancer risk of hypertensive patients taking calcium antagonistsD J Hole, C R Gillis, I R McCallum, et al.
Lancet (London, England)|July 31, 1998
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Is cancer related to hypertension or to its treatment?A F Lever, D J Hole, C R Gillis, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failureC W Howden, C D Payton, P A Meredith, et al.
British Journal of Clinical Pharmacology|October 1, 1991
A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteersJ D Gemmill, C A Howie, P A Meredith, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?A F Lever, D G Beevers, D J Hole, et al.
Journal of Hypertension|April 9, 1998
Cancer risk of hypertensive patients taking calcium antagonistsD J Hole, C R Gillis, I R McCallum, et al.
Lancet (London, England)|July 31, 1998
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.
Pageof 21